as 09-08-2025 4:00pm EST
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Founded: | 1999 | Country: | United States |
Employees: | N/A | City: | NASHVILLE, |
Market Cap: | 48.5M | IPO Year: | 2009 |
Target Price: | N/A | AVG Volume (30 days): | 51.6K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.21 | EPS Growth: | N/A |
52 Week Low/High: | $1.04 - $7.25 | Next Earning Date: | 11-06-2025 |
Revenue: | $42,071,813 | Revenue Growth: | 11.34% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Young Caroline | CPIX | N/A | Jul 31 '25 | Buy | $3.50 | 6 | $21.00 | 32,821 | |
Krogulski Kenneth | CPIX | N/A | Jul 31 '25 | Buy | $3.50 | 68 | $238.00 | 288,345 | |
Jones James | CPIX | N/A | Jul 31 '25 | Buy | $3.50 | 13 | $45.50 | 43,676 | |
KAZIMI A J | CPIX | Chairman and CEO | Jul 31 '25 | Buy | $3.50 | 13 | $45.50 | 5,699,768 | |
Young Caroline | CPIX | N/A | Jul 30 '25 | Buy | $3.55 | 6 | $21.30 | 32,821 | |
Krogulski Kenneth | CPIX | N/A | Jul 30 '25 | Buy | $3.55 | 68 | $241.40 | 288,345 | |
Jones James | CPIX | N/A | Jul 30 '25 | Buy | $3.55 | 13 | $46.15 | 43,676 | |
KAZIMI A J | CPIX | Chairman and CEO | Jul 30 '25 | Buy | $3.55 | 13 | $46.15 | 5,699,768 | |
Young Caroline | CPIX | N/A | Jul 29 '25 | Buy | $3.33 | 6 | $19.98 | 32,821 | |
Krogulski Kenneth | CPIX | N/A | Jul 29 '25 | Buy | $3.33 | 68 | $226.44 | 288,345 |
CPIX Breaking Stock News: Dive into CPIX Ticker-Specific Updates for Smart Investing
PR Newswire
3 months ago
Simply Wall St.
3 months ago
PR Newswire
3 months ago
MT Newswires
4 months ago
PR Newswire
4 months ago
GuruFocus.com
4 months ago
PR Newswire
4 months ago
PR Newswire
4 months ago
The information presented on this page, "CPIX Cumberland Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.